(CIDRAP News) In the largest study of its kind so far to assess how well 2009 H1N1 vaccines performed in the pandemic setting, new findings from seven European countries showed they provided good protection, a result that mirrors early clinical studies.
(CIDRAP News) Obesity as a risk factor for severe illness and death was one of the clinical surprises that emerged early in the 2009 H1N1 pandemic, and now California researchers have shown that extreme obesity is an independent risk factor for death from the disease.
(CIDRAP News) The winter flu season is now officially under way in the Northern Hemisphere, the World Health Organization (WHO) reported today in releasing its most recent influenza data.
Meanwhile, US data also released today show influenza activity again rising, and a third report says flu activity is increasing dramatically in the United Kingdom.
(CIDRAP News) In two new reports, the Canadian government gives itself a generally good grade for its response to the H1N1 pandemic but also lists many areas for improvement.
"Overall, the response of [health authorities] to the H1N1 pandemic is considered to have been effective," says the Public Health Agency of Canada's (PHAC's) report, released yesterday. The report covers the actions of that agency and of Health Canada.
Dec 30, 2010
Dec 28, 2010
(CIDRAP News) Influenza activity jumped in the United States last week along with other Northern Hemisphere locations, and an official from the World Health Organization (WHO) said it's not yet clear if this season will make its mark as a bad one.
(CIDRAP News) The European Centre for Disease Prevention and Control (ECDC) today said flu transmission is increasing across the European Union (EU), led by a spike in the United Kingdom, and warned people in recommended groups to get vaccinated as soon as possible.
(CIDRAP News) – With signs that the flu season is picking up momentum, the Department of Health and Human Services (HHS) today unveiled a demonstration project to raise flu vaccination rates in minority groups, backed by $10 million worth of vaccine vouchers from Walgreens.
